Rankings
▼
Calendar
UTHR FY 2020 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
UTHR
United Therapeutics Corporation
$24B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.5B
+2.4% YoY
Gross Profit
$1.4B
92.7% margin
Operating Income
$594M
40.0% margin
Net Income
$515M
34.7% margin
EPS (Diluted)
$11.54
Cash Flow
Operating Cash Flow
$756M
Free Cash Flow
$696M
Stock-Based Comp.
$164M
Balance Sheet
Total Assets
$4.6B
Total Liabilities
$1.2B
Stockholders' Equity
$3.4B
Cash & Equivalents
$739M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.5B
$1.4B
+2.4%
Gross Profit
$1.4B
$1.3B
+3.3%
Operating Income
$594M
-$188M
+416.4%
Net Income
$515M
-$105M
+592.6%
← Q4 2019
All Quarters
Q1 2020 →